Targeted Protein Degradation for CNS

Delivering and Translating Degraders of Extracellular and Intracellular CNS Proteins

Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States

Prices:
Conference Only – Drug Developer : USD 2599.00,
Conference + 1 Workshop – Drug Developer: USD 3098.00,
Full Conference Access – Drug Developer: USD 3597.00,
Conference Only – Solution Provider: USD 3799.00
Conference + 1 Workshop – Solution Provider: USD 4548.00
Full Conference Access – Solution Provider: USD 5297.00

Time: 09:00 to 16:45

Speakers: Andrew Zhang – Director – AstraZeneca, Bart Westerman – Assistant Professor – Amsterdam UMC, Beth Hoffman – Chief Executive Officer – Origami Therapeutics, Charlie Hao – Bicentennial Chair and Professor – Indiana University School of Medicine, Demetrios Kostomiris – Senior Research Scientist – AstraZeneca,  and more